Where To Buy Sklice Lotion
CLICK HERE ->->->-> https://walllowcopo.blogspot.com/?download=2tEdEh
BRIDGEWATER, N.J., Feb. 7, 2012 /PRNewswire/ -- Sanofi announced today that the U.S. Food and Drug Administration (FDA) has approved Sklice (ivermectin) lotion, 0.5% for the topical treatment of head lice, in patients 6 months of age and older. Effective and well-tolerated, Sklice Lotion treats lice in most patients with a single 10-minute application of the lotion, without nit combing.
Appropriate studies performed to date have not demonstrated pediatric-specific problems that would limit the usefulness of ivermectin topical lotion in children 6 months of age and older. However, use is not recommended in infants younger than 6 months of age.
Sklice is supplied as a lotion for topical treatment. Sklice should be applied to dry hair in an amount sufficient (up to one tube) to thoroughly coat the scalp and hair. Leave Sklice on the hair and scalp for 10 minutes and then rinse off with water.
Medicines can interact with certain foods. In some cases, this may be harmful and your doctor may advise you to avoid certain foods. In the case of ivermectin lotion and tablets, there are no specific foods that you must exclude from your diet.
If you apply too much ivermectin lotion to your scalp, you are not likely to experience severe side effects. However, if this medication in taken by mouth, call your local Poison Control Center or seek emergency medical attention right away.
Today, the U.S. Food and Drug Administration approved a lotion to treat head lice for nonprescription, or over-the-counter (OTC), use through a process called a prescription (Rx)-to-OTC switch. The FDA initially approved Sklice (ivermectin) lotion, 0.5% for the treatment of head lice infestation in patients 6 months of age and older as a prescription drug in February 2012.
In the United States, it is estimated that between 6 and 12 million cases of head lice infestation occur each year in children 3 to 11 years of age, according to the U.S. Centers for Disease Control and Prevention. Head lice are most common among preschool children attending child care, elementary school children and members of a household where children have lice.
Sklice is a single-use lotion with ivermectin 0.5% as the active ingredient, for the topical treatment of head lice infestations in patients 6 months of age and older. Sklice is for external use only and should only be used on the scalp and dry hair in accordance with label directions. Sklice is not approved for any other use.
The FDA granted the approval of nonprescription Sklice (ivermectin) lotion, 0.5% for the topical treatment of head lice infestations in patients 6 months of age and older to Arbor Pharmaceuticals LLC.
Evidence shows that 50% of lice cases are resistant to the current treatments available on drug store shelves, but these treatments still are a good first-line defense. According to Jill Hefti, a family nurse practioner, following the product directions in conjunction with daily combing with a lice comb carries little risk and is relatively cost effective. When patients present with lice to the practice where she works with family practice physician Jesse Haven, M.D., they provide patient education on how to rid the home and hair of the parasite.
In addition to Sklice, two other prescription products have been approved recently. Spinosad topical suspension 9% (brand name Natroba) and benzyl alcohol 5% lotion (brand name Ulesfia). Natroba is a combination of an organic pesticide often seen in flea medication for pets combined with benzyl alcohol that boasts 85% success 14 days after a single treatment. The downside? Its safety has not been approved in children under age 4. Ulesfia relies on the benzyl alcohol to suffocate the live lice, which is not considered a pesticide and is safe for children age six months and older. The major warning here is that these two products are flammable, so staying away from a spark is mandatory.
Apply a sufficient amount of lotion (up to 1 tube) to thoroughly coat dry hair and.